Only four patients over 60 years (60, 62, 65, and 71 y) were vaccinated against Cabozantinib purchase yellow fever, and only one who was in good physiological condition and traveled to Benin for 2 weeks received a primary vaccination. In this case the benefit of vaccination was assessed to be superior to risk. All 413 travelers needing vaccination and presenting no contra-indication

were vaccinated (100%, 95% CI: 99–100%). Although South Africa and the Comoros Islands are not endemic for yellow fever and vaccination is not recommended, three patients, however, received yellow fever vaccination without indication as they were traveling to these two countries.9 All the travel destinations were considered as at risk for hepatitis A. As many as 276 patients were considered immune to hepatitis A. Among the non-immune patients (n = 454), 442 patients were vaccinated (97.4%, 95% CI: 95.4–98.5%) against hepatitis A. Five patients refused vaccination (1.1%) Roxadustat purchase and vaccination was not proposed to seven patients (1.5%). To improve the services for travelers at our travel medicine and vaccine center, we wanted to increase our knowledge about the adequacy of the advice given to travelers

to national guidelines. We selected three fields of interest: malaria prevention, yellow fever, and hepatitis A vaccinations, which are key to safe travels in the tropics, and performed a 3-month prospective study before summer holidays. These three fields of interest are relevant since 83% of our travelers visited malaria-endemic areas, 74% visited yellow fever-endemic areas, and all of them were exposed to the risk of hepatitis A. Previous studies

have also shown that 35 to 49% of travelers to Africa carried either no or inappropriate prophylaxis.10,11 Overall our results look quite satisfactory since adequacy to national guidelines was above 95% for all three diseases. These results were obtained in the setting of a study of 730 travelers, assessing real prescriptions from physicians. These results compare favorably to results obtained in previous studies assessing the quality of travel medicine, most of which used questionnaires.12–18 Interestingly, doxycycline was the most frequent chemoprophylaxis prescribed for malaria in this study (48% of all prescriptions). This drug is the cheapest anti-malaria prophylaxis not in France, and is as effective as the other drugs.19–21 It is also well tolerated, with a better tolerability profile than mefloquine.22–24 The limitation for its use is the need to continue treatment for 4 weeks after leaving the malaria-endemic area, with a risk for suboptimal adherence23–24 and travelers who want to sunbathe, because of the risk of phototoxicity. During the 3-month period of the study, 413 travelers received yellow fever vaccination. This represents a large number of vaccinations as compared to travel centers in most parts of Europe.25 There are a number of potential explanations for these good results.

Burkholderia DBT1, a bacterial strain isolated from oil refinery drainage, has been shown to be capable of degrading DBT in liquid culture oxidatively, through the Kodama pathway, within 3 days of incubation (Di Gregorio et al., 2004). Because DBT behaves as a recalcitrant compound and tends to bioaccumulate throughout the food chains, the isolation and characterization of bacterial strains able to degrade condensed thiophenes, using them as the sole source of carbon and energy, can result in applications in bioremediation protocols. Nevertheless, for the harmless exploitation of Burkholderia DBT1 in environmental biotechnology, a probative exclusion

of this strain from the B. cepacia complex is a prerequisite. The versatile metabolism of DBT1 towards PAHs such as naphthalene, phenanthrene and fluorene shown in the present study is an

encouraging trait for the possible use of this strain see more in the clean-up of contaminated sites. Moreover, the taxonomic details gained in this study attribute the strain DBT1 to the species fungorum, excluding any possible association of this isolate to the Bcc. The authors thank the Academy of Finland (grant no. 118637) for support. “
“Two strains of aerobic acidophilic chemoorganotrophic selleck chemicals bacteria designed strains AP8T and AP9 were isolated from acid mine drainage and acidic soil, respectively. These isolates were Gram-negative, nonmotile cocci and coccobacilli measuring 0.5–0.8 μm in diameter. Cells were capsulated. Colonies on solid media were pink colored. The pH range for growth was 3.0–6.0 (optimum pH 4.5). Sugars, gluconate, and some amino acids were good carbon and energy sources for growth. The main components of cellular fatty acids were C15:0 iso and C16:1ω7c. Menaquinone-8 was the major quinone. The G+C content of genomic DNA was 59.5%. Both strains had identical sequences of 16S rRNA genes that were most closely related to that of the type strain of Acidobacterium capsulatum (96% similarity). There were major differences between the isolates and A. capsulatum in cell morphology, carbon nutrition, and fatty acid profiles. Based on these phylogenetic and phenotypic data, we propose the name Acidipila

rosea gen. nov., sp. nov. to accommodate NADPH-cytochrome-c2 reductase the novel isolates. The type strain is AP8T (NBRC 107607T, KCTC 23427T). Culture-independent molecular approaches have revealed the widespread occurrence of members of the phylum ‘Acidobacteria’ in nature. Large numbers of 16S rRNA gene clones of this phylum have been retrieved from soils (Janssen, 2006; Otsuka et al., 2008; Kenzaka et al., 2010), sediments (Dunbar et al., 1999; Barns et al., 2007), wastewater (LaPara et al., 2000; Narihiro et al., 2009), acid mine drainage (AMD) (Diaby et al., 2007; Tan et al., 2007), and hot springs (Hobel et al., 2005). The biodiversity of the Acidobacteria is potentially as great as that of the phylum Proteobacteria (Ludwig et al., 1997; Hugenholtz et al., 1998). Barns et al.

Burkholderia DBT1, a bacterial strain isolated from oil refinery drainage, has been shown to be capable of degrading DBT in liquid culture oxidatively, through the Kodama pathway, within 3 days of incubation (Di Gregorio et al., 2004). Because DBT behaves as a recalcitrant compound and tends to bioaccumulate throughout the food chains, the isolation and characterization of bacterial strains able to degrade condensed thiophenes, using them as the sole source of carbon and energy, can result in applications in bioremediation protocols. Nevertheless, for the harmless exploitation of Burkholderia DBT1 in environmental biotechnology, a probative exclusion

of this strain from the B. cepacia complex is a prerequisite. The versatile metabolism of DBT1 towards PAHs such as naphthalene, phenanthrene and fluorene shown in the present study is an

encouraging trait for the possible use of this strain 3-MA research buy in the clean-up of contaminated sites. Moreover, the taxonomic details gained in this study attribute the strain DBT1 to the species fungorum, excluding any possible association of this isolate to the Bcc. The authors thank the Academy of Finland (grant no. 118637) for support. “
“Two strains of aerobic acidophilic chemoorganotrophic Ponatinib order bacteria designed strains AP8T and AP9 were isolated from acid mine drainage and acidic soil, respectively. These isolates were Gram-negative, nonmotile cocci and coccobacilli measuring 0.5–0.8 μm in diameter. Cells were capsulated. Colonies on solid media were pink colored. The pH range for growth was 3.0–6.0 (optimum pH 4.5). Sugars, gluconate, and some amino acids were good carbon and energy sources for growth. The main components of cellular fatty acids were C15:0 iso and C16:1ω7c. Menaquinone-8 was the major quinone. The G+C content of genomic DNA was 59.5%. Both strains had identical sequences of 16S rRNA genes that were most closely related to that of the type strain of Acidobacterium capsulatum (96% similarity). There were major differences between the isolates and A. capsulatum in cell morphology, carbon nutrition, and fatty acid profiles. Based on these phylogenetic and phenotypic data, we propose the name Acidipila

rosea gen. nov., sp. nov. to accommodate learn more the novel isolates. The type strain is AP8T (NBRC 107607T, KCTC 23427T). Culture-independent molecular approaches have revealed the widespread occurrence of members of the phylum ‘Acidobacteria’ in nature. Large numbers of 16S rRNA gene clones of this phylum have been retrieved from soils (Janssen, 2006; Otsuka et al., 2008; Kenzaka et al., 2010), sediments (Dunbar et al., 1999; Barns et al., 2007), wastewater (LaPara et al., 2000; Narihiro et al., 2009), acid mine drainage (AMD) (Diaby et al., 2007; Tan et al., 2007), and hot springs (Hobel et al., 2005). The biodiversity of the Acidobacteria is potentially as great as that of the phylum Proteobacteria (Ludwig et al., 1997; Hugenholtz et al., 1998). Barns et al.

This should be reflected in an increase in Bcl-2 inhibitor the number of peaks in the alpha topography from the undivided condition to the divided condition. For the blinking spotlight model

of attention (VanRullen et al., 2007), we derived three possible predictions for suppression of the to-be-ignored stimuli. In this theory, the attentional spotlight is thought to constantly move between all available stimuli. Therefore, the first prediction is that all unattended stimuli will be suppressed individually. That is, we assume that a similar mechanism exists for both suppression and excitation. For the current experimental paradigm, such a mechanism would result in two peaks of suppression for both the divided attention condition and the undivided attention condition. The second prediction is that there will be no suppression of to-be-ignored stimuli, as the blinking spotlight of attention might only selectively enhance target locations. This should obviously result in alpha topographies that do not possess selleck chemicals distinctive occipito-parietal peaks. The third prediction is that, while the attentional focus switches rhythmically between all possible target locations, suppression will be allocated to distracter

locations in a static fashion. This would result in the same topographic distribution and increase in the number Fludarabine concentration of peaks in the divided attention condition as for the divided spotlight account, and indicate a static split of suppression. Participants were successful at performing the difficult attentional tasks.

With chance level at 33.3%, the mean percentages of correct responses were approximately 50% for the attentional task conditions involving the outer right stimulus, and approximately 45% for those involving the left outer stimulus (Fig. 3). These performance values are somewhat lower than in other studies of attention, but the experimental task was more difficult, owing to the randomly flickering stimuli that were necessary to estimate the brain’s impulse response to all four stimuli. For the C1 time-frame, the repeated measures anova revealed no significant main effects (F1,54 = 0.2; P = 0.657). Only for the inner left stimulus was there significant modulation of activity with attention (F1,13 = 4.78; P = 0.048). This indicates that there was no influence of attention on cortical processing in this very early time-frame, or that the locations of the four different stimuli were not optimal for obtaining C1 responses.

There was no evidence of an association between maximum height reached and absolute risk benefit (data not shown, p = 0.36). There was an association between rate of ascent and absolute risk benefit. The model was best fitted when the rate of ascent was log transformed (Figure 5B, p = 0.005). One study included the prevention of high altitude pulmonary edema as a primary end point.[30] However, no cases of this condition occurred in the trial. Other studies did not systematically report the presence or absence of pulmonary or cerebral edema. Most trials

did not systematically report adverse effects. In those trials that did report adverse effects, they were reported commonly but were usually not severe. The most commonly reported adverse effects were paraesthesia, urinary frequency, and dysgeusia. see more On pooled analysis, paraesthesia and dysgeusia were more common in the acetazolamide group (p < 0.0001 and p = 0.016, respectively). However, in those trials that systematically reported adverse effects, discontinuation STA-9090 ic50 of study medication due to adverse effects was unusual. It was not possible to perform meta-analysis investigating the impact of dose on rate of adverse effects since the number of studies involving each dose was small with significant heterogeneity. One study reported a direct comparison between 250 and 750 mg/d.[33] It found that paraesthesia was more common in the 750 mg/d group with a

trend toward increased incidence of dysgeusia. This Cepharanthine systematic review synthesized data from rando-mized-controlled trials investigating the efficacy of acetazolamide prophylaxis in the prevention of altitude sickness. It found a significant benefit associated with acetazolamide treatment that was remarkably consistent across a range of heterogeneous trials. Overall, the meta-analysis suggested that taking acetazolamide prophylaxis is associated with a relative-risk reduction of around 48%. There was no evidence of any difference in efficacy between different doses of acetazolamide. This conclusion differs from that of Dumont and colleagues who concluded that while 750 mg/d was effective, lower doses were not.[5]

This difference is likely due to three principal factors: most importantly, there have been a significant number of new trials published since 2000, many of which examined lower doses of acetazolamide. Furthermore, the inclusion criteria of our study were different as we included only double-blind studies. Finally, while our primary end point was relative-risk reduction, in Dumont and colleagues it was NNT, which may have made comparison between trials difficult given the heterogeneity in risk of AMS between trials. It is of note that the two different types of study included, expedition-based and location-based studies, did not differ in their estimate of treatment efficacy despite marked differences in the design of the two study types.

We found that the in vitro transcription start sites of the novel SdrP-regulated genes were 6–7 bp downstream from the predicted −10 hexamers of their promoters and around 40 bp downstream of the putative SdrP-binding sites, as in the cases of the previously identified SdrP-regulated genes (Fig. 2a and Fig. S2) (Agari et al., 2008). We investigated the sequence conservation of the putative binding-sequences of 16 SdrP-regulated promoters including

those identified in the previous study (Agari et al., 2008) (Fig. 2a and b). The results indicate that the left arm of the putative binding-sites is relatively conserved as TTGTG, but the right arm is not except for two C bases (Fig. 2b). Table 2 summarizes the eight genes that are under the

control of the SdrP-dependent promoter found in this study. The gene products include manganese superoxide dismutase (TTHA0557) (Ludwig et al., 1991; Peterson et al., 1991) and catalase (TTHA1625) (Rehse et al., 2004), FK506 nmr which are involved in the oxidative stress response, and excinuclease ABC subunit B (UvrB) (TTHA1892) (Nakagawa et al., 1999), which plays a central role in the nucleotide excision repair of damaged DNA. According to blast searches, the functions of the other gene products were predicted to be in redox control (TTHA1215, TTHA1635, and TTHB132), protein degradation (TTHA1128), and transcriptional regulation (TTHA0029). Expression of the genes also tended to increase upon entry into the stationary phase, as in the case of the

previously identified GW-572016 research buy SdrP-regulated genes (Table 1). We could not find the predicted SdrP-binding sequence close to the promoter regions of the 16 genes whose expression showed strong negative correlation with that of the sdrP gene, suggesting that SdrP does not act mafosfamide as a transcription repressor. Thus, including the 14 previously identified genes, a total of 22 genes have been identified as SdrP-regulated genes. We analyzed the altered expression profiles of the 22 SdrP-regulated genes in cells perturbed by the various stresses, and found that the expression of most genes increased with these perturbations (Table 1). The altered expression profile caused by 2 mM diamide treatment was the most similar to that upon entry into the stationary growth phase (Table 1). The expression level did not always correlate with that of the sdrP gene, especially in response to perturbation by 50 mM tetracycline, in which the expression of 13 genes was significantly decreased (Table 1). These results suggest that depending on the stress, not only the signal via SdrP, but also other signal(s) are transmitted to the cells to alter expression of the SdrP-regulated genes. Using expression pattern analysis of a large amount of DNA microarray data, we found eight new SdrP-regulated genes that were not identified in previously studies using comparative expression analysis of the wild-type and ΔsdrP strains (Agari et al., 2008).

, 2007). In fact, survival of bacteria in natural settings largely depends on its phenotypic plasticity, because altered phenotype see more influences the interaction of bacteria with its surrounding physicochemical environment, and thereby affects the ecological fitness of organism (Henderson et al., 1999; Palkova, 2004; Chantratita et al., 2007). Thus, from health as well as ecological perspectives, bacterial

genes involved in community establishment have received much attention. Pseudomonas alkylphenolia KL28 degrades 4-n-alkylphenol (C1–C5) using a novel catabolic pathway encoded by the lap catabolic gene cluster, which is distantly related to phenol and methyl-phenol-degrading genes of other Pseudomonas sp. (Jeong et al., 2003). This bacterium forms specialized aerial structures (SAS), which are beneficial for the utilization of vapor substrates and for survival under drying and starvation conditions. Under such conditions, P. alkylphenolia KL28 can survive for more than

a year and their SAS has been shown to form ultramicrocells by reductive division (Lee & Veeranagouda, 2009). In this study, a transposon mutant showing defect in SAS development was characterized to determine the gene(s) involved in SAS formation. Pseudomonas click here alkylphenolia strain KL28 (Jeong et al., 2003) was cultured either in Luria–Bertani (LB) medium or in minimal salts basal (MSB) medium (Stanier et al., http://www.selleck.co.jp/products/cobimetinib-gdc-0973-rg7420.html 1966) with an appropriate carbon source. For growth on agar surfaces, cells were cultured on MSB or LB medium with 1.5% agar. Congo red (CR) at a final concentration of 80 mg L−1 was added to prepare LB-CR agar medium. The detailed culture

conditions for strains KL28 and Escherichia coli and the concentration of antibiotics for plasmid maintenance have been described previously (Yun et al., 2007). A KL28 transposon mutant library was generated using the transposon delivery vector pRL27 (Larsen et al., 2002), and disrupted genes were identified as described previously (Yun et al., 2007). Sequence homology between proteins was calculated using the bioedit program (http://www.mbio.ncsu.edu/BioEdit/page2.html). The nucleotide sequence identified in this study was deposited in the NCBI GenBank database and the accession number is HM172486. An in-frame ssg deletion mutant of KL28 was constructed by allelic replacement as described by Schafer et al. (1994). For this study, a gene fragment containing about 70% deletion of the internal region of ssg was created by overlap extension PCR as described previously (Ho et al., 1989). The primers used were dSsgFBHI, 5′-GGATCCTGGCCCATGACTGTT-3′, (BamHI, underlined); dSsgIR, 5′ GCCGATGCGCAGGTTGCGCTGATCGGC-3′; dSsgIF, 5′-GCGACCCTGGCGATCGGCAGCACCGGT-3′ and dSsgRSphI, 5′- GCATGCGGCTTCCAGTGTTCC-3′ (SphI, underlined).

2% HBV+HCV) and 16% (114 of 699) of treatment-experienced patients (6% HBV only, 9% HCV only and 1% HBV+HCV). Among treatment-naïve patients receiving raltegravir, median

CD4 cell count and median HIV RNA level at baseline were similar between hepatitis B/C-positive and hepatitis B/C-negative patients. Among treatment-experienced patients receiving raltegravir, the median CD4 cell count was slightly higher and the median HIV RNA level was slightly lower in those with hepatitis coinfection. Panobinostat The incidence of drug-related clinical adverse events was similar in raltegravir recipients with hepatitis coinfection compared with those without coinfection in both STARTMRK (50 vs. 47%) and BENCHMRK (34 vs. 38.5%). The incidence of hepatobiliary adverse events was low overall and was not affected by hepatitis Selleck YAP-TEAD Inhibitor 1 coinfection status (Table 2). Specific events reported in coinfected patients were hepatitis, bile duct

stone and cholelithiasis; in patients without hepatitis coinfection, the specific hepatobiliary events were hepatic failure, hepatic pain, hepatic steatosis, hepatitis, hepatomegaly, hyperbilirubinaemia, jaundice, portal hypertension, cholangitis, cholecystitis, cholelithiasis, cholestasis, gallbladder disorder and gallbladder polyp. In both the treatment-naïve and treatment-experienced populations, grade 2–4 elevations in AST, ALT and total bilirubin levels were more common in patients with hepatitis coinfection than in those with HIV infection only (Table 2); this difference was observed in the raltegravir treatment groups as well as the control groups (efavirenz in STARTMRK and OBT in BENCHMRK). After 96 weeks of treatment, raltegravir displayed similar antiviral and immunological effects in HIV-infected patients with and without HBV and/or HCV coinfection (Table 3). HIV RNA <50 copies/mL was achieved in 93% Non-specific serine/threonine protein kinase of treatment-naïve patients with

hepatitis coinfection compared with 90% of patients without HBV or HCV infection. Similarly, HIV RNA <50 copies/mL was achieved in 63 and 61%, respectively, of treatment-experienced patients with and without hepatitis coinfection. The mean change from baseline in CD4 cell count also was similar for raltegravir recipients with and without hepatitis coinfection in both the treatment-naïve and treatment-experienced populations (Table 3). Severe hepatotoxicity has been reported in up to 23% of patients receiving antiretroviral therapy for HIV infection [10]. Risk factors for hepatotoxic events include baseline elevation in serum aminotransferase or total bilirubin levels, coinfection with HBV or HCV, pre-existing liver insufficiency and certain antiretroviral drugs, specifically, stavudine, didanosine, nevirapine, full-dose ritonavir and tipranavir [7–10]. The hepatic effects of newer antiretroviral drugs will be an important consideration in the selection of therapeutic regimens for patients with HIV and hepatitis coinfection.

The prevalence of other alarm symptoms were as follows: 52 cases of indigestion lasting longer than 3 weeks or have not been relieved by over-the-counter medicines; 21 cases of blood in stools or diarrhoea lasting longer than 3 weeks; 19 cases of haematuria, 12 cases of unintentional weight loss; 11 cases of dysphagia; 13 cases of rectal bleeding; 8 cases of breast lumps; and 9 cases of haemoptysis. Patients with white British ethnic

origin were most likely to present. Over 60% of patients presenting were female and the most common age range was 55 to 64 years. Our results show that patients with alarm symptoms do present at the community pharmacy looking for healthcare advice GSK1120212 in vivo and/or something to manage their symptoms. The most common alarm symptom was a cough lasting longer than 3 weeks; this can be associated Ixazomib manufacturer with lung cancer.[1] Indeed, as lung cancer is the most common cause of cancer death in the UK, it is imperative to detect this it as soon as possible in order to improve treatment outcomes and patient survival. This has also been recently publicized by the recent national public health campaign Be Clear on Cancer,[2] urging anyone with a cough lasting for 3 or more weeks to visit their GP for further tests. There is, therefore, potential to develop an intervention to promote early cancer detection

– with a possible focus on lung cancer – in the community pharmacy. 1. Early detection of lung cancer. A guide to delivering brief interventions. Available at: http://www.cancerresearchuk.org/cancer-info/prod_consump/groups/cr_common/@nre/@hea/documents/generalcontent/cr_043916.pdf [accessed 13.04.14] 2. Be Clear on Cancer: lung cancer campaign. Available at: http://www.cancerresearchuk.org/cancer-info/spotcancerearly/naedi/beclearoncancer/lung/ [accessed 13.04.14] H. Kinseya, S. Scahillb, L. Byec, J. Harrisonc aUniversity of Nottingham, Nottingham,

UK, bMassey University, Palmerston North, New Zealand, cUniversity of Auckland, Auckland, New Zealand The new pharmacy contract in New Zealand aims to provide a more patient-centred model of care. Pharmacists supported the concept of a more patient-centred agreement. Pharmacists reported difficulties understanding the contract and concerns regarding an increase in their workload. A new community pharmacy contract known as the Community Pharmacy Services Agreement buy Cetuximab (CPSA) was introduced in New Zealand (NZ) in July 2012. The agreement introduces a mixed fee-for-service and capitation payment funding model covering three areas of pharmacy services: a Core Service, a Long-Term Conditions Service (LTC) and Specific Services. This study aims to explore the views of community pharmacists in NZ to the CPSA 18 months after its implementation. This qualitative study used a semi-structured interview comprised of twelve topics for discussion. A purposive sampling approach drew participants from a matrix designed to ensure a maximum variation sample.

MTT solution was added into the wells and incubated for 2 h. After the medium was removed, DMSO was added to each well. BYL719 in vitro The plates were gently agitated until the color reaction was uniform, and the OD570 was determined using a microplate reader (Wellscan MK3; Labsystems Dragon). Media-only treated cells with DMSO served as the indicator of 100% cell viability. Antifungal activity tests showed that inhibition zone diameters of the crude extract against Phomopsis asparagi, Polystigma deformans, Cladosporium cucumerinum, Monilinia fructicola, and Colletotrichum lagenarium were 15, 25, 20,

15, and 20 mm, respectively; however, the inhibition zone diameters of blank groups were only 6 mm, which implied great Everolimus potential of Streptomyces sp. W007 in agricultural fungal disease control. Genome sequence of Streptomyces sp. W007 revealed the presence of 149 open reading frames (ORFs) in the contig 151. A homology search showed that some ORFs were homologous to angucyclinone derivatives biosynthesis genes reported previously. Based on their positions and deduced functions, we identified 20 ORFs (from ORF 4216 to 4235, named ang 1 to ang 20) probably involved in the biosynthesis of angucyclinone antibiotics (Fig. 1). The putative functions of ORFs and the closest homologues are shown

in Table 1. According to blastp results with NCBI nr database, ang 2 shows high percent identity (93%) to SAM-dependent methyltransferase from Streptomyces griseus IFO 13350 (Ohnishi et al., 2008), which can regulate spore development and antibiotic synthesis (Bao et al., 2010). Ang 4 is identified as hydrolase (Ohnishi et al., 2008). Ang 7 and ang 5 are in accordance with short-chain dehydrogenase/reductase (SDR) and 3-oxoacyl-(acyl carrier protein) reductase, which catalyze the reduction in ketone group. Ang 10 shares 56% amino acid identity with O-methyltransferase of

Streptomyces sp. 2238-SVT4 (Kawasaki et al., 2010). Ang 11 is a FAD-binding hydroxylase similar to the Chorioepithelioma type II polyketide gene cluster from Streptomyces fradiae (Decker & Haag, 1995). Ang 12 has high similarity of 89% to cyclase in Streptomyces sp. SCC2136 (Basnet et al., 2006). In the gene cluster of angucyclinone antibiotics, the mini PKS is found to be composed of ang 13, 14, and 15 that present the functions of ketoacyl synthase (KSα), chain length factor (KSβ), and ACP, respectively. Ang 16 shows similarity to ketone group reductase of urdamycin A biosynthesis and can be assigned to reduce C-9 (Decker & Haag, 1995). Ang 17 and 20 show high percent identities to aromatase from Streptomyces sp. SCC 2136 (Basnet et al., 2006) and acetyl-coenzyme A carboxyl transferase alpha chain in Streptomyces venezuelae ATCC 10712 (Pullan et al., 2011), respectively. Ang 18 and 19 show sequence similarities to oxygenase reductase and ketoacyl reductase from Streptomyces sp. 2238-SVT4 (Kawasaki et al., 2010).